Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04685616
Title Brentuximab Vedotin in Early Stage Hodgkin Lymphoma (RADAR)
Acronym RADAR
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA | NZL | NLD | GBR | ESP | BEL | AUS


No variant requirements are available.